1. 調査手法および対象範囲
1.1. 調査手法
1.2. 調査目的およびレポートの対象範囲
2. 定義および概要
3. エグゼクティブサマリー
3.1. 製品種類別抜粋
3.2. 解像度種類別抜粋
3.3. 用途別抜粋
3.4. エンドユーザー別抜粋
3.5. 地域別
4. ダイナミクス
4.1. 影響因子
4.1.1. 推進要因
4.1.1.1. 低侵襲処置に対する需要の高まり
4.1.1.2. XX
4.1.2. 抑制要因
4.1.2.1. 機器の高コスト
4.1.3. 機会
4.1.4. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
6. 製品種類別
6.1. はじめに
6.1.1. 分析および前年比成長率（％）の種類別
6.1.2. 市場魅力度指数（種類別
6.2. 内視鏡画像化システム*
6.2.1. はじめに
6.2.2. 市場規模の分析および前年比成長率（％）
6.2.3. 高級画像化システム
6.2.4. ミドルエンド内視鏡可視化装置
6.2.5. ローエンド内視鏡可視化装置
6.3. 内視鏡画像処理コンポーネント
6.3.1. カメラヘッド
6.3.2. モニター
6.3.3. 光源
6.3.4. インフレータ
6.3.5. ビデオプロセッサ
6.3.6. プリンター
7. 解像度種類別
7.1. はじめに
7.1.1. 市場規模分析および前年比成長率（％） 解像度種類別
7.1.2. 市場魅力度指数 解像度種類別
7.2. 4K*
7.2.1. はじめに
7.2.2. 市場規模分析および前年比成長率分析（％）
7.3. FHD
8. 用途別
8.1. はじめに
8.1.1. 市場規模分析および前年比成長率分析（％）、用途別
8.1.2. 市場魅力度指数、用途別
8.2. 消化器科*
8.2.1. はじめに
8.2.2. 市場規模および前年比成長率（％）
8.3. 婦人科
8.4. 泌尿器科
8.5. 整形外科
8.6. 循環器科
8.7. その他
9. エンドユーザー別
9.1. はじめに
9.1.1. エンドユーザー別市場規模分析および前年比成長率（％）
9.1.2. エンドユーザー別市場魅力度指数
9.2. 病院および専門クリニック*
9.2.1. イントロダクション
9.2.2. 市場規模分析および前年比成長率（％）
9.3. 画像診断センター
9.4. その他
10. 地域別
10.1. はじめに
10.1.1. 市場規模分析および前年比成長率分析（％）、地域別
10.1.2. 市場魅力度指数、地域別
10.2. 北米
10.2.1. はじめに
10.2.2. 主な地域特有の動向
10.2.3. 市場規模分析および前年比成長率（％）製品種類別
10.2.4. 市場規模分析および前年比成長率（％）解像度種類別
10.2.5. 市場規模分析および前年比成長率（％）用途別
10.2.6. エンドユーザー別市場規模分析および前年比成長率分析（％）
10.2.7. 国別市場規模分析および前年比成長率分析（％）
10.2.7.1. 米国
10.2.7.2. カナダ
10.2.7.3. メキシコ
10.3. ヨーロッパ
10.3.1. はじめに
10.3.2. 主要地域別の動向
10.3.3. 製品種類別市場規模分析および前年比成長率（％）
10.3.4. 解像度種類別市場規模分析および前年比成長率（％）
10.3.5. 用途別市場規模分析および前年比成長率（％）
10.3.6. エンドユーザー別市場規模分析および前年比成長率分析（％）
10.3.7. 国別市場規模分析および前年比成長率分析（％）
10.3.7.1. ドイツ
10.3.7.2. 英国
10.3.7.3. フランス
10.3.7.4. スペイン
10.3.7.5. イタリア
10.3.7.6. ヨーロッパのその他地域
10.4. 南アメリカ
10.4.1. はじめに
10.4.2. 主要地域別の動向
10.4.3. 市場規模分析および前年比成長率分析（％）、製品種類別
10.4.4. 解像度種類別市場規模分析および前年比成長率（％）
10.4.5. 用途別市場規模分析および前年比成長率（％）
10.4.6. エンドユーザー別市場規模分析および前年比成長率（％）
10.4.7. 国別市場規模分析および前年比成長率（％）
10.4.7.1. ブラジル
10.4.7.2. アルゼンチン
10.4.7.3. 南米その他
10.5. アジア太平洋地域
10.5.1. はじめに
10.5.2. 地域特有の主な動向
10.5.3. 市場規模分析および前年比成長率分析（％）、製品種類別
10.5.4. 解像度種類別市場規模分析および前年比成長率（％）
10.5.5. 用途別市場規模分析および前年比成長率（％）
10.5.6. エンドユーザー別市場規模分析および前年比成長率（％）
10.5.7. 国別市場規模分析および前年比成長率（％）
10.5.7.1. 中国
10.5.7.2. インド
10.5.7.3. 日本
10.5.7.4. 韓国
10.5.7.5. アジア太平洋地域その他
10.6. 中東およびアフリカ
10.6.1. はじめに
10.6.2. 主要地域特有の動向
10.6.3. 製品種類別市場規模分析および前年比成長率（％）
10.6.4. 解像度種類別市場規模分析および前年比成長率（％）
10.6.5. 用途別市場規模分析および前年比成長率（％）
10.6.6. 市場規模分析および前年比成長率分析（％）、エンドユーザー別
11. 競合状況
11.1. 競合シナリオ
11.2. 市場ポジショニング/シェア分析
11.3. 合併・買収分析
12. 企業プロフィール
Olympus
Boston Scientific Corporation
Medtronic
KARL STORZ
Stryker Corporation
Fujifilm Corporation
CONMED Corporation.
Pentax Medical (Hoya Group)
Richard Wolf GmbH.
Smith+Nephew.
リストは網羅的なものではありません。
13. 付録
13.1. 当社およびサービスについて
13.2. お問い合わせ
The global endoscopy visualization systems market reached US$ 17.82 billion in 2023 and is expected to reach US$ 29.94 billion by 2031, growing at a CAGR of 6.7 % during the forecast period 2024-2031.
Endoscopy visualization systems are advanced medical instruments designed to deliver high-resolution images of internal organs and structures during endoscopic procedures. These systems comprise various components, including cameras, light sources, monitors, and video processors, which collaborate to provide healthcare providers with clear and detailed visual information. They are crucial in numerous medical fields, such as gastrointestinal, urology, gynecology, and orthopedics.
These advanced systems enhance the imaging quality during endoscopic examinations, allowing for improved diagnosis and treatment of various conditions. By utilizing high-definition (HD) and ultra-high-definition (UHD) technologies, these devices facilitate the accurate identification of lesions and other abnormalities. The integration of artificial intelligence further boosts their capabilities by enabling real-time analysis and assistance during procedures. Overall, endoscopy visualization systems are essential tools that significantly improve the effectiveness and safety of minimally invasive surgeries. These factors have driven the global endoscopy visualization systems market expansion.
Market Dynamics: Drivers & Restraints
Rising Demand for Minimally Invasive Procedures
The rising demand for minimally invasive procedures is significantly driving the growth of the global endoscopy visualization systems market and is expected to drive throughout the market forecast period.
The increasing preference for minimally invasive surgeries (MIS) is a crucial driver in the endoscopy visualization systems market. This trend is primarily attributed to the numerous advantages associated with minimally invasive techniques, which are revolutionizing surgical practices across various medical fields.
Minimally invasive procedures typically involve smaller incisions, leading to less trauma to the body. As a result, patients often experience quicker recovery times compared to traditional open surgeries. Many individuals can resume their normal activities within days rather than weeks, enhancing overall patient satisfaction and encouraging more people to choose these procedures.
Smaller incisions generally result in less postoperative pain and discomfort. Patients undergoing minimally invasive surgeries frequently report significantly lower pain levels, which can often be managed with over-the-counter medications instead of stronger narcotics. This reduction in pain not only improves the patient experience but also minimizes the risks associated with opioid use.
Furthermore, key players in the industry product launches and approvals that would drive this global endoscopy visualization systems market growth. For instance, in September 2022, Olympus Corporation announced the launch of the VISERA ELITE III, its latest surgical visualization platform designed to meet the diverse needs of healthcare professionals (HCPs) performing endoscopic procedures across various medical disciplines. This advanced system aims to enhance surgical capabilities by integrating multiple imaging functions into a single platform, facilitating minimally invasive therapies such as Laparoscopic Colectomy and Laparoscopic Cholecystectomy.
Also, in February 2024, PENTAX Medical received CE marks for its new models in the i20c Video Endoscope Series, which includes the PENTAX Medical Video Colonoscope EC34-i20c, PENTAX Medical Video Upper GI Scope EG27-i20c, and the R/L Knob Adaptor OE-B17. These advancements aim to enhance the capabilities of healthcare professionals in detection, diagnosis, and therapy during endoscopic procedures. All these factors demand the global endoscopy visualization systems market.
Moreover, the rising demand for technological advancements contributes to the global endoscopy visualization systems market expansion.
High Costs of Equipment
The high costs of equipment will hinder the growth of the global endoscopy visualization systems market. The significant investment needed for advanced endoscopy visualization systems is expensive. The high expenses related to the purchase, installation, and ongoing maintenance of these systems can discourage healthcare facilities, especially in developing regions where financial resources are more constrained. This economic barrier restricts the adoption of new technologies and may hinder overall global endoscopy visualization systems market growth.
The pricing structure for endoscopy visualization systems reflects a balance between technological advancements, brand value, and market demand. As per LabX Media Group in 2024, with new systems ranging from $20,000 to $150,000 and used options available from $5,000 to $75,000, healthcare facilities have various choices that can fit different financial capacities while still enhancing their diagnostic and surgical capabilities. This flexibility in pricing is crucial for expanding access to advanced medical technologies across diverse healthcare settings. Thus, the above factors could be limiting the global endoscopy visualization systems market's potential growth.
Segment Analysis
The global endoscopy visualization systems market is segmented based on product type, resolution type, application, end-user, and region.
Product Type:
The endoscopy visualization systems segment is expected to dominate the global endoscopy visualization systems market share.
The endoscopy visualization systems segment holds a major portion of the global endoscopy visualization systems market share and is expected to continue to hold a significant portion of the global endoscopy visualization systems market share during the forecast period.
The endoscopy visualization systems segment within the larger endoscopy visualization systems market is a crucial area focusing on advanced technologies that enhance the visualization of internal structures during endoscopic procedures. This segment is essential for improving diagnostic accuracy and treatment outcomes across various medical fields.
Endoscopy visualization systems are sophisticated video systems designed to deliver high-definition images and videos during endoscopic surgeries. These systems significantly improve imaging quality, enabling healthcare professionals to visualize internal anatomy with greater clarity and precision.
The endoscopy visualization systems typically consist of several key components including cameras, monitors, light sources, video processors, and printers. The segment can be categorized based on the level of technology and features offered High-End visualization systems, mid-range, and low-end systems. These options offer basic imaging capabilities suitable for less complex procedures, making them more accessible to a broader range of healthcare facilities.
Furthermore, key players' strategies such as partnerships & collaborations, and product launches would drive this segment growth in the global endoscopy visualization systems market. For instance, in September 2022, Endoluxe announced a significant development agreement with Synodic aimed at enhancing its advanced technology capabilities in the medical field, particularly in endoscopic visualization. This partnership is set to leverage Synopic's expertise in image sensing, machine learning, and visualization technologies to create an innovative Endoluxe Visualization System (EVS), which promises to revolutionize how endoscopic procedures are conducted.
Also, in November 2021, Fujifilm launched the ColoAssist PRO, a real-time endoscope visualization system designed to assist endoscopists during colonoscopies. This system is part of Fujifilm’s ELUXEO Ultra family of technologies and aims to enhance the efficiency and accuracy of colonoscopic procedures. The ColoAssist PRO allows clinicians to visualize the configuration of the endoscope throughout the procedure. This feature is crucial for helping healthcare professionals maneuver the colonoscope accurately within the patient’s colon, which can be complex due to the organ's anatomy. These factors have solidified the segment's position in the global endoscopy visualization systems market.
Geographical Analysis
North America is expected to hold a significant position in the global endoscopy visualization systems market share
North America holds a substantial position in the global endoscopy visualization systems market and is expected to hold most of the market share.
The increasing occurrence of chronic diseases, including gastrointestinal disorders, cancer, and obesity, is a significant concern in North America. For instance, according to the American Cancer Society projected that in January 2024, there would be approximately 106,590 new cases of colon cancer expected to be diagnosed, with 54,210 cases in men and 52,380 cases in women.
Additionally, there will be about 46,220 new cases of rectal cancer, comprising 27,330 cases in men and 18,890 cases in women. This escalating disease burden creates a heightened demand for effective diagnostic and treatment options, particularly advanced endoscopy visualization systems.
There is a rising preference for minimally invasive surgical techniques due to their numerous benefits, such as shorter recovery times, reduced pain levels, and lower risks of complications. Endoscopy visualization systems are crucial for these types of procedures, as they enable surgeons to perform intricate operations with enhanced precision and less trauma to patients.
Ongoing advancements in imaging technology have significantly improved the quality of endoscopic images. High-definition (HD) and ultra-high-definition (UHD) systems provide clearer visuals, while innovations like artificial intelligence (AI) integration for real-time lesion detection further enhance diagnostic capabilities. These technological improvements make endoscopy visualization systems more attractive to healthcare providers.
Furthermore, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, government initiatives & regulatory support, investments, and product launches & approvals would propel the global endoscopy visualization systems market.
For instance, in October 2023, Olympus Corporation announced the market launch of its next-generation EVIS X1 endoscopy system. This advanced system is designed to improve gastrointestinal (GI) diagnostics and treatment, showcasing Olympus's commitment to innovation in medical technology in Canada. Thus, the above factors are consolidating the region's position as a dominant force in the global endoscopy visualization systems market.
Asia Pacific is growing at the fastest pace in the global endoscopy visualization systems market
Asia Pacific holds the fastest pace in the global endoscopy visualization systems market and is expected to hold most of the market share.
The prevalence of chronic diseases, particularly gastrointestinal disorders, cancer, and obesity, is on the rise in the Asia-Pacific region. This increase creates a greater need for effective diagnostic and treatment options, including advanced endoscopy visualization systems. The growing patient population requiring endoscopic interventions drives demand for these technologies.
There is a notable shift towards minimally invasive surgical techniques due to their associated benefits, such as shorter recovery times, reduced pain, and lower risk of complications. Endoscopy visualization systems are essential for these procedures, enabling surgeons to perform complex operations with enhanced precision and less trauma to patients.
Continuous innovations in imaging technology, including high-definition (HD) and ultra-high-definition (UHD) systems, have significantly improved the quality of endoscopic images. The integration of artificial intelligence (AI) for real-time lesion detection further enhances diagnostic capabilities, making these systems more appealing to healthcare providers.
Furthermore, major players in the region, government initiatives, and investments, enhanced awareness among patients and physicians, increased healthcare expenditure, and product launches that would drive this endoscopy visualization systems market growth. For instance, in September 2024, Stryker announced the launch of its innovative 1788 Advanced Imaging Platform in India. This platform represents Stryker's most comprehensive and sophisticated surgical visualization system to date, designed to enhance imaging capabilities across multiple medical specialties and improve patient outcomes.
Thus, the above factors are consolidating the region's position as the fastest-growing force in the global endoscopy visualization systems market.
Competitive Landscape
The major global players in the endoscopy visualization systems market include Olympus, Boston Scientific Corporation, Medtronic, KARL STORZ, Stryker Corporation, Fujifilm Corporation, CONMED Corporation., Pentax Medical (Hoya Group), Richard Wolf GmbH., and Smith+Nephew. among others.
Emerging Players
The emerging players in the global endoscopy visualization systems market include Ambu Inc., Surgical Science, and Endoluxe among others.
Key Developments
• In September 2024, Olympus Latin America announced the launch of the EVIS X1 endoscopy system in Brazil, marking the introduction of their most advanced endoscopy technology. This system is designed to enhance the detection and treatment of gastrointestinal diseases, particularly colorectal cancer.
• In September 2024, Olympus Corporation, announced the launch of its new 4K camera head, designated CH-S700-08-LB, specifically designed for endoscopic procedures in urology and gynecology. This innovative camera head is compatible with the VISERA ELITE III video system center, which is utilized for surgical endoscopy.
Why Purchase the Report?
• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.
The global endoscopy visualization systems market report would provide approximately 70 tables, 63 figures, and 183 pages.
Target Audience 2023
• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Resolution Type
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Demand for Minimally Invasive Procedures
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High Costs of Equipment
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. By Product Type
6.1. Introduction
6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Endoscopy Visualization Systems*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. High-End Visualization Systems
6.2.4. Middle-End Visualization Systems
6.2.5. Low-End Visualization Systems
6.3. Endoscopy Visualization Components
6.3.1. Camera Heads
6.3.2. Monitors
6.3.3. Light Sources
6.3.4. Insufflators
6.3.5. Video Processors
6.3.6. Printers
7. By Resolution Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Resolution Type
7.1.2. Market Attractiveness Index, By Resolution Type
7.2. 4K*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. FHD
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Gastroenterology*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Gynecology
8.4. Urology
8.5. Orthopedic
8.6. Cardiology
8.7. Others
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals & Specialty Clinics*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Diagnostic Imaging Centers
9.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Resolution Type
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Resolution Type
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. U.K.
10.3.7.3. France
10.3.7.4. Spain
10.3.7.5. Italy
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Resolution Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Resolution Type
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. South Korea
10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Resolution Type
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Olympus*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Boston Scientific Corporation
12.3. Medtronic
12.4. KARL STORZ
12.5. Stryker Corporation
12.6. Fujifilm Corporation
12.7. CONMED Corporation.
12.8. Pentax Medical (Hoya Group)
12.9. Richard Wolf GmbH.
12.10. Smith+Nephew.
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us
*** 内視鏡可視化装置の世界市場に関するよくある質問(FAQ) ***
・内視鏡可視化装置の世界市場規模は？
→DataM Intelligence社は2023年の内視鏡可視化装置の世界市場規模を178.2億米ドルと推定しています。
・内視鏡可視化装置の世界市場予測は？
→DataM Intelligence社は2031年の内視鏡可視化装置の世界市場規模を299.4億米ドルと予測しています。
・内視鏡可視化装置市場の成長率は？
→DataM Intelligence社は内視鏡可視化装置の世界市場が2024年～2031年に年平均6.7%成長すると展望しています。
・世界の内視鏡可視化装置市場における主要プレイヤーは？
→「Olympus、Boston Scientific Corporation、Medtronic、KARL STORZ、Stryker Corporation、Fujifilm Corporation、CONMED Corporation.、Pentax Medical (Hoya Group)、Richard Wolf GmbH.、Smith+Nephew.など ...」を内視鏡可視化装置市場のグローバル主要プレイヤーとして判断しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
